• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周动脉疾病的预防方面

Preventive aspects in peripheral artery disease.

作者信息

Aggarwal Saurabh, Loomba Rohit Seth, Arora Rohit

出版信息

Ther Adv Cardiovasc Dis. 2012 Apr;6(2):53-70. doi: 10.1177/1753944712437359. Epub 2012 Feb 15.

DOI:10.1177/1753944712437359
PMID:22337767
Abstract

The prevalence of peripheral artery disease is steadily increasing and is associated with significant morbidity, including a significant percentage of amputations. Peripheral artery disease often goes undiagnosed, making its prevention increasingly important. Patients with peripheral arterial disease are at increased risk of adverse cardiovascular outcomes which makes prevention even more important. Several risk factors have been identified in the pathophysiology of peripheral artery disease which should be modified to decrease risk. Smoking, hyperlipidemia, hypertension, and diabetes are among proven risk factors for the development of peripheral artery disease, thus smoking cessation, lipid control, blood pressure control, and glucose control have been tried and shown to be effective in preventing the morbidity associated with this disease. Pharmacologic agents such as aspirin and clopidogrel alone or in combination have been shown to be effective, though risk of bleeding might be increased with the combination. Anticoagulation use is recommended only for acute embolic cases. Other treatment modalities that have been tried or are under investigation are estrogen replacement, naftidrofuryl, pentoxifylline, hyperbaric oxygen, therapeutic angiogenesis, and advanced glycation inhibitors. The treatment for concomitant vascular diseases does not change in the presence of peripheral artery disease, but aggressive management of risk factors should be undertaken in such cases.

摘要

外周动脉疾病的患病率正在稳步上升,且与严重的发病率相关,包括相当比例的截肢病例。外周动脉疾病常常未被诊断出来,因此其预防变得越发重要。外周动脉疾病患者发生不良心血管事件的风险增加,这使得预防更为重要。在外周动脉疾病的病理生理学中已确定了若干风险因素,应对这些因素加以改变以降低风险。吸烟、高脂血症、高血压和糖尿病是外周动脉疾病发生的已证实的风险因素,因此,戒烟、控制血脂、控制血压和控制血糖已被尝试并证明在预防与此疾病相关的发病率方面是有效的。单独使用或联合使用阿司匹林和氯吡格雷等药物已被证明是有效的,不过联合使用可能会增加出血风险。仅在急性栓塞病例中推荐使用抗凝治疗。其他已被尝试或正在研究的治疗方式包括雌激素替代疗法、萘呋胺酯、己酮可可碱、高压氧、治疗性血管生成和晚期糖基化抑制剂。在外周动脉疾病存在的情况下,对合并的血管疾病的治疗并无改变,但在这种情况下应积极管理风险因素。

相似文献

1
Preventive aspects in peripheral artery disease.外周动脉疾病的预防方面
Ther Adv Cardiovasc Dis. 2012 Apr;6(2):53-70. doi: 10.1177/1753944712437359. Epub 2012 Feb 15.
2
Optimal medical management of peripheral arterial disease.外周动脉疾病的优化医疗管理
Vasc Endovascular Surg. 2006 Aug-Sep;40(4):312-27. doi: 10.1177/1538574406291835.
3
[Prevention of cerebrovascular circulatory disorders].[预防脑血管循环障碍]
Fortschr Neurol Psychiatr. 1985 Sep;53(9):337-43. doi: 10.1055/s-2007-1001977.
4
Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".关于“外周动脉疾病的药理学危险因素管理:血管外科医生手册”。
J Vasc Surg. 2008 Sep;48(3):776-7; author reply 777. doi: 10.1016/j.jvs.2008.04.074.
5
Medical management of critical limb ischaemia: where do we stand today?严重肢体缺血的医学治疗:我们今天处于什么位置?
J Intern Med. 2013 Oct;274(4):295-307. doi: 10.1111/joim.12102. Epub 2013 Jul 22.
6
Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons.外周动脉疾病的药物风险因素管理:血管外科医生手册
J Vasc Surg. 2008 May;47(5):1108-15. doi: 10.1016/j.jvs.2007.12.033. Epub 2008 Apr 18.
7
Optimal risk factor modification and medical management of the patient with peripheral arterial disease.外周动脉疾病患者的最佳危险因素修正与药物治疗
Catheter Cardiovasc Interv. 2008 Mar 1;71(4):475-89. doi: 10.1002/ccd.21401.
8
Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.外周动脉疾病的药物风险因素治疗尚不完善,需要血管外科医生的参与。
Ann Vasc Surg. 2007 Mar;21(2):163-6. doi: 10.1016/j.avsg.2007.01.008.
9
Classical risk factors and emerging elements in the risk profile for coronary artery disease.冠状动脉疾病风险概况中的经典危险因素和新出现的因素。
Eur Heart J. 1998 Feb;19 Suppl A:A53-61.
10
Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none.外周动脉疾病的抗栓治疗——抗血小板治疗、抗凝治疗、两者皆用或两者皆不用。
Thromb Haemost. 2010 Aug;104(2):196-9. doi: 10.1160/TH10-02-0104. Epub 2010 May 27.

引用本文的文献

1
Effects of Aerobic Exercise on Irisin and Skeletal Muscle Autophagy in Mice.有氧运动对小鼠鸢尾素及骨骼肌自噬的影响
Curr Issues Mol Biol. 2025 May 19;47(5):371. doi: 10.3390/cimb47050371.
2
A Perfect Storm: Case of Chronic Albumin Loss, Multi-Morbidity and Antibiotic Resistance.一场完美风暴:慢性白蛋白丢失、多种疾病并存与抗生素耐药病例
Curr Health Sci J. 2024 Oct-Dec;50(5):607-611. doi: 10.12865/CHSJ.50.04.15. Epub 2024 Dec 31.
3
High-Intensity Interval Training and Moderate-Intensity Continuous Training Attenuate Oxidative Damage and Promote Myokine Response in the Skeletal Muscle of ApoE KO Mice on High-Fat Diet.
高强度间歇训练和中等强度持续训练可减轻高脂饮食的载脂蛋白E基因敲除小鼠骨骼肌的氧化损伤并促进肌动蛋白反应。
Antioxidants (Basel). 2021 Jun 22;10(7):992. doi: 10.3390/antiox10070992.
4
Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease.外周动脉粥样硬化、西方饮食与骨骼肌病理生理学的十字路口:重点关注载脂蛋白 E 缺乏症与外周动脉疾病。
J Biomed Sci. 2017 Jul 8;24(1):42. doi: 10.1186/s12929-017-0346-8.